The origin of metastatic disease: clues from genomics 7/13/2011.

Slides:



Advertisements
Similar presentations
Neoplasia II: Tumor Characteristics
Advertisements

Hereditary GI Cancer Syndromes: Keys to identify high risk patients
Acquisition of tumour multidrug resistance inevitable in most advanced solid tumours – Failing to cure the majority of advanced solid tumours – Declining.
Shyamala Maherswaran, Ph.D. et al. Sarah Gomez and Rachael Holmes Detection of Mutations in EGFR in Circulating Lung-Cancer Cells.
Possible Link between Cancer Multidrug Resistance and Epigenetics Erin Wildeman, Marcos Pires, PhD Lehigh University Department of Chemistry, Bethlehem,
Metastasis. Mechanisms of Invasion and Metastasis.
Ancha Baranova George Mason University, Fairfax, VA
Special Topics in Modern Genetics: Epigenetics
Expression profiles for prognosis and prediction Laura J. Van ‘t Veer The Netherlands Cancer Institute, Amsterdam.
Estrogen and its receptors play an important role in breast carcinogenesis. In humans, there are two subtypes of estrogen receptors (ER), ER  and ER ,
Overdiagnosis as an extreme form of length-time bias Breast cancer screening as example Juan Gérvas, MD, PhD, Equipo CESCA, Madrid, Spain
Master in Advanced Genetics
Polymorphisms – SNP, InDel, Transposon BMI/IBGP 730 Victor Jin, Ph.D. (Slides from Dr. Kun Huang) Department of Biomedical Informatics Ohio State University.
BRCA Genes Dallas Henson.
Genomics Lecture 7 By Ms. Shumaila Azam. Tumor Tumor – abnormal proliferation of cells that results from uncontrolled, abnormal cell division A tumor.
Comprehensive Gene Expression Analysis of Prostate Cancer Reveals Distinct Transcriptional Programs Associated With Metastatic Disease Kevin Paiz-Ramirez.
Cancer. Tumors arise from normal tissues Tumors are created by cells that have lost the ability to assemble and create tissues of normal form and function.
Understanding and Optimizing Treatment of Triple Negative Breast Cancer Edith Peterson Mitchell, MD, FACP Clinical Professor of Medicine and Medical Oncology.
Metastatic Breast Cancer: One Size Does Not Fit All Clifford Hudis, M.D. Chief, Breast Cancer Medicine Service MSKCC.
Building a Model of Tumorigenesis: A small group activity for a Cancer Biology/Cell Biology course L. K. Wright Supplemental File : Multistep Tumorigenesis.
Understanding Cancer and Related Topics
SC430 Molecular Cell Biology
Copyright © 2009 Pearson Education, Inc. Essentials of Genetics Seventh Edition Klug, Cummings, Spencer, Palladino Chapter 16 Cell Cycle Regulation and.
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria Cancer Biology.
Investigating the use of Multiple Displacement Amplification (MDA) to amplify nanogram quantities of DNA to use for downstream mutation screening by sequencing.
Genetics-multistep tumorigenesis genomic integrity & cancer Sections from Weinberg’s ‘the biology of Cancer’ Cancer genetics and genomics Selected.
Characteristics of Cancer. Promotion (reversible) Initiation (irreversible) malignant metastases More mutations Progression (irreversible)
23.1 Cancer Is a Group of Diseases Characterized by Cell Proliferation.
We obtained breast cancer tissues from the Breast Cancer Biospecimen Repository of Fred Hutchinson Cancer Research Center. We performed two rounds of next-gen.
Genetics of Cancer Genetic Mutations that Lead to Uncontrolled Cell Growth.
Copy Number Variation Eleanor Feingold University of Pittsburgh March 2012.
Tumor Markers American cancer society British Journal of Cancer By B.Heidari.
Cancer 101: A Cancer Education and Training Program for American Indians & Alaska Natives Cancer 101: A Cancer Education and Training Program for American.
Lecture 11. Topics in Omic Studies (Cancer Genomics, Transcriptomics and Epignomics) The Chinese University of Hong Kong CSCI5050 Bioinformatics and Computational.
Presented by: Dr/Fedaa Abd-Elmonem Clinical pharmacy instructor Tanta University.
Breast Cancer: BRCA1/2 Erin Hayes Foundations of Medicine Blue Valley CAPS October 28,
Regulating The Cell Cycle. Warm Up – The Cell Cycle The cell spends 80% of the time in _______________ and 20% of the time in ________________ What are.
PHL 472 Chemical Carcinogens Abdelkader Ashour, Ph.D. 2 nd Lecture.
INTERPRETING GENETIC MUTATIONAL DATA FOR CLINICAL ONCOLOGY Ben Ho Park, M.D., Ph.D. Associate Professor of Oncology Johns Hopkins University May 2014.
Have a positive role in cell division Have a negative role in cell division Have a role in the maintenance of DNA integrity Genes altered in cancer typically:
Samuel Aparicio, B.M., B.Ch., Ph.D., and Carlos Caldas, M.D.
Prepared by : Dr. Nehad J. Ahmed. Cancer is a disease that results from abnormal growth and differentiation of tissues. Tumor or neoplasm - A mass of.
Cancer Bioinformatics Tom Doman Bioinformatics Scientist Eli Lilly & Company Informatics 519 guest lecture IU Bloomington Sept
Genome evolution within the individual
Molecular Biology of Cancer AND Cancer Informatics (omics) David Boone.
GENETICS A Conceptual Approach
GENETIC BIOMARKERS.
Cancer – a disease of many mutations
Neoplasia lecture4 Dr Heyam Awad FRCPath.
GENETIC BASIS OF CANCER
Volume 1, Issue 1, Pages (February 2002)
Figure 1 Comparison of tumor size at time of excision between axillary node-negative, axillary node-positive, and distant metastasis subgroups of basal-like.
CANCER.
Cancer as a genetic disease
Van’t Veer et al, Nature 415: (2002)
Origins of Metastatic Traits
PTEN (a.k.a. MMAC1 and TEP1) and Cowden’s Disease
Clonal evolution in Ewing sarcoma.
WES detects a limited number of clinically targetable alterations in patients with advanced cancer. WES detects a limited number of clinically targetable.
Volume 4, Issue 1, Pages 4-6 (July 2003)
High Frequency of Loss of Heterozygosity on Chromosome Region 9p21–p22 but Lack of p16INK4a/p19ARF Mutations in Greek Patients with Basal Cell Carcinoma.
Cancer Stem Cells: Current Status and Evolving Complexities
Comparison of Genetic Profiles Between Primary Melanomas and their Metastases Reveals Genetic Alterations and Clonal Evolution During Progression  Reiji.
Example inverse FF-OCT images (left column) and corresponding histology images (right column) of ovarian metastases. Example inverse FF-OCT images (left.
Delineating cancer evolution with single-cell sequencing
Molecular heterogeneity can drive mixed response and treatment failure in EGC. A, PET images from Patient #4 obtained before treatment and upon disease.
Location of the ER mutations and frequencies per cohort.
Single nucleotide polymorphism array analysis can distinguish different genetic mechanisms that lead to loss of heterozygosity (LOH). Single nucleotide.
Detection of E-cadherin fragments in human prostate cancer metastases.
Genomic instability is a core feature of ovarian cancer that frequently involves DNA-damage repair genes. Genomic instability is a core feature of ovarian.
Presentation transcript:

The origin of metastatic disease: clues from genomics 7/13/2011

Tumor evolution

Metastasis: Current questions When do tumor cells leave the primary tumor? Are metastases clonal? Do metastases evolve at the metastatic site? Do different tumor types have different metastatic origins? Nguyen, D. J Pathol 2011; 223:

Why do we care? Treatment for metastasis is virtually non-existent Some treatments increase the likelihood of metastasis Analyzing the primary tumor may indicate the genetic make-up of metastases Diagnostics do not exist for metastases, but may be required if metastases are genetically dissimilar to the primary tumor CSCs might be a source of metastasis that are refractory to current treatment

Genomic studies of metastases How do we track the differences between primary tumors and mets? Loss of heterozygosity: two distinct alleles exist in normal tissue, one is lost in tumor Copy number: number of alleles or chromosomes increases or decreases Epigenetic markers: methylation states

Loss of heterozygosity Caused by – Non-disjunction – Recombination – Double strand break repair – Deletion Detect with SNPs or microsatelllites

Copy Number Measure of genomic instability Detected by sequencing (single cell) or CGH (tissue)

CGH Comparative Genomic Hybridization Label tumor vs. normal tissue

Metastasis: Current questions When do tumor cells leave the primary tumor? Are metastases clonal? Do metastases evolve at the metastatic site? Do different tumor types have different metastatic origins? Nguyen, D. J Pathol 2011; 223:

Metastasis: Current questions When do tumor cells disseminate? – Early: DTCs or Mets have fewer or different mutations than the primary tumor – Late: DTCs or Mets look like aggressive primary tumor Are metastases clonal? – The entire met or all mets in the body look the same Do metastases evolve at the metastatic site? – No: Mets look like primary tumor – Yes: Mets show significant divergence from the primary tumor Do different tumor types have different metastatic origins? – Mets look like primary tumor in some cancers – Mets look different than primary tumor in other cancers

When do tumor cells disseminate?

Disseminated tumor cells Metastasis Primary tumor

DTCs often do not cluster with metastases or primary tumors

Conclusions and Caveats DTCs exist very early in tumor progression Cytokeratin marker causes bias

Are Metastases Clonal?

Copy Number Analysis Liu et al. Nature Medicine 15, (2009)

Metastases are clonal in prostate cancer Metastases found in different regions of the body are clonal, implying a single cell of origin Liu et al. Nature Medicine 15, (2009)

Metastases are not clonal in breast cancer Wu et al. Clin Cancer Res April 1, ; 1938

Primary tumors are similar to metastases

Copy number analysis of single cells 6% coverage Navin et al. Nature 472, 90–94 (07 April 2011)

Copy number analysis of single cells in breast tumors Stromal cells Tumor cells Navin et al. Nature 472, 90–94 (07 April 2011)

Copy number analysis of single cells

Clinical examples of tracing metastatic origin Breast cancer – Her2-pos – 65 PTs with 42 macrometastases and 18 micrometastases – In HER-2-positive PTs, 26 of 29 metastases were HER-2-positive – HER-2 amplification and ER and PR status were conserved in mets in 71% of cases Strein et al. Pathol Res Pract Apr 15;206(4):253-8

Similarities between primary tumor and metastases in colorectal cancer Jones et al. PNAS March 18, 2008 vol. 105 no

Screened 233 known mutations in PTs and Mets Only seven not found in both Jones et al. PNAS March 18, 2008 vol. 105 no

Implications of this data Mets arise late from aggressive, advanced carcinoma cells Implies that genes required for primary tumor growth might confer metastatic ability

Primary tumors are significantly different than metastases

Clinical examples of tracing metastatic origin Fehm et al. Breast Cancer Research :R59

Clinical examples of tracing metastatic origin Fehm et al. Breast Cancer Research :R59

Significant divergence of Mets from PTs in breast cancer Ramaswamy et al. Nature Genetics 33, (2002)

Methylation states change between primary tumor and metastases in prostate cancer Prostate cancer cell lines Yegnasubramanian et al. Cancer Res March 15, ; 1975

Methylation states change between primary tumor and metastases Yegnasubramanian et al. Cancer Res March 15, ; 1975

Methylation states change between primary tumor and metastases Yegnasubramanian et al. Cancer Res March 15, ; 1975

Hypermethylation occurs in breast cancer metastases Mehrotra et al. Clin Cancer Res. Vol. 10, , 2004.

Interpretations of this data Metastases require additional mutations to successfully grow at a distant site Three possible scenarios: – Metastatic cells leave the primary tumor early on – Metastatic cells leave the primary tumor late but then require additional mutations to colonize a distant organ – Clones exist in primary tumor but are not detected

The best current example of using genomics to understand metastatic origin

Metastases occur late in pancreatic cancer Yachida et al. Nature 467, 1114–1117 (28 October 2010)

Conclusions Some metastases are genetically similar to the primary tumor, while others are not Metastases can be clonal or heterogeneous Information from primary tumor could help to determine characteristics about metastases Primary tumor diagnostics may not be sufficient Origin of metastatic precursor may be early or late in tumor progression These studies imply that it may not be cancer-type dependent Studies are limited…

Stoecklein, N. H. and Klein, C. A. (2010). International Journal of Cancer, 126: 589–598.

Conclusions Seems to be mostly patient or study dependent!

Future directions Next generation sequencing – Can get more accurate data – Single cell resolution Analysis of CTCs and DTCs “Personalized medicine”